Advancing Smoking Cessation: FDA and NIH Priorities

Sep.23.2024
Advancing Smoking Cessation: FDA and NIH Priorities
FDA and NIH will host a public meeting on Oct 21 to promote smoking cessation innovations for adults and youth.

On September 20th, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will jointly host a public meeting titled "Advancing the End of Tobacco Addiction: FDA and NIH Priorities" on October 21st from 9:00 am to 4:30 pm. The purpose of this meeting is to promote innovation in smoking cessation products to assist adults and adolescents in quitting smoking.


The conference will feature multiple speeches and panel discussions on smoking cessation. Topics of discussion will include perspectives from clinical and community settings, promising areas for development targets, and future regulatory pathways. Additionally, the conference will provide an opportunity for open commentary, allowing the public to voice opinions on various related topics.


This conference is open to the public free of charge. It is worth noting that in-person participation requires registration by October 15, 2024, and virtual attendance can be registered by 9 a.m. (EDT) on the day of the conference. If you wish to speak during the public comment session in person, registration must be completed by 5 p.m. (EDT) on October 1st.


Written reviews must be submitted by November 21, 2024 through the Regulations.gov public docket archive [Docket No. FDA-2024-N-4085].


The U.S. Department of Health and Human Services (HHS) support and accelerate smoking cessation framework clearly outlines the goal of promoting continued and innovative research on smoking cessation. The agency stated that the joint FDA and NIH meeting in October was specifically to support these efforts, aimed at driving a collective effort across society to improve the nation's health.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | DOJO OPAL Series Launches COSMOS E-Cigarette Featuring Sweetness, Coolness, and Acidity Flavor Profiles
Product | DOJO OPAL Series Launches COSMOS E-Cigarette Featuring Sweetness, Coolness, and Acidity Flavor Profiles
E-cigarette brand DOJO has recently launched the new COSMOS edition under its DOJO OPAL series, which includes a total of three products. Despite its more compact size, the COSMOS edition retains a 16ml e-liquid capacity and an 800mAh battery, offering up to 12,000 puffs. The product also features detailed labeling of flavor attributes, including sweetness, coolness, and acidity levels.
Jun.13 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs Statement on FDA Marketing Authorization
JUUL Labs said its e-cigarettes have received FDA marketing granted orders (MGOs), meeting the “public health” standard. It noted it is the only major vaping firm not backed by a traditional tobacco company.
Jul.18
UK Media: After the Ban on Disposable E-cigarettes Takes Effect, Most Users Switch to Rechargeable Products
UK Media: After the Ban on Disposable E-cigarettes Takes Effect, Most Users Switch to Rechargeable Products
After the UK's ban on disposable e-cigarettes in June, vape shops report mixed impacts. Some owners see increased sales as customers switch to rechargeable products, while others note a decline in overall sales due to the ban.
Jun.10 by 2FIRSTS.ai
Asia-Pacific Tobacco Harm Reduction Advocates Criticize WHO Policy Shift, Say It Harms India and Other Low- and Middle-Income Countries
Asia-Pacific Tobacco Harm Reduction Advocates Criticize WHO Policy Shift, Say It Harms India and Other Low- and Middle-Income Countries
The Asia-Pacific Coalition on Tobacco Harm Reduction (CAPHRA) warns that WHO’s recent policy shift contradicts evidence and harms low- and middle-income countries like India, which has over 45 million livelihoods tied to tobacco. CAPHRA criticizes WHO’s double standard of banning safer alternatives in poorer countries but not in high-income ones, increasing health inequality.
Jul.23 by 2FIRSTS.ai
Ireland's E-Waste Surges 75%: E-Cigarettes Dominate the Market—Can Recycling Systems Keep Up?
Ireland's E-Waste Surges 75%: E-Cigarettes Dominate the Market—Can Recycling Systems Keep Up?
Ireland’s 2024 Annual Report shows electronic device sales rose 75% in five years, reaching 93 million units—driven largely by e-cigarettes (one-third of sales) and solar panels. Recycling improved, but e-cigarette systems lag. The government pledged €27 million to boost the circular economy.
Jun.19 by 2FIRSTS.ai